Organotin compound DBDCT induces CYP3A suppression through NF-κB-mediated repression of PXR activity
Organotin anticancer agent di-n-butyl-di-(4-chlorobenzohydroxamato)tin(iv) (DBDCT) exerted an inhibitory effect on its major metabolic enzyme cytochrome CYP3A.
2009 ◽
Vol 14
(6)
◽
pp. 947-957
◽
2018 ◽
Vol 370
(2)
◽
pp. 454-460
◽
Keyword(s):
2017 ◽
Vol 8
(1)
◽
pp. 21
◽
Keyword(s):
Keyword(s):
2000 ◽
Vol 7
(3)
◽
pp. 167-169
◽
Keyword(s):